Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide vs metformin for new-onset diabetes after renal transplantation
ChiCTR2300078600Phase 4Not yet recruiting
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Dec 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: Glycosylated hemoglobin (HbA1c). Planned start Dec 2023; status: not yet recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2300078600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078600.